Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

AACR 2015 /
Pembrolizumab found to be safe with durable responses in advanced non-small cell lung cancer

18th - 22nd Apr 2015

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 01.05.15
Views: 2625
Rating:

Dr Edward Garon - David Geffen School of Medicine at the University of California, Los Angeles, USA

Dr Garon talks to ecancertv at AACR 2015 about the results of a trial looking at the use of pembrolizumab in the treatment of advanced, non-small cell lung cancer.

Read the news story or watch the press conference video for more.

 

 

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation